Patents by Inventor Christopher Cheadle

Christopher Cheadle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Networking device with an electronically steerable directional antenna array
    Patent number: 9615266
    Abstract: In one embodiment, a networking device comprises a first plurality of antenna means, a second plurality of antenna means, and means for controlling the first and second pluralities of antenna means to direct a communication towards a neighbor node of the device.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: April 4, 2017
    Assignee: Cisco Technology, Inc.
    Inventors: Christopher A. Cheadle, Steven Anthony Granzella, John A. Bentley
  • Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
    Patent number: 6217866
    Abstract: Hybridoma cell lines producing monoclonal antibodies specific to the human epidermal growth factor receptor are disclosed. The antibodies are capable of inhibiting the growth of human tumor cells expressing human epidermal growth factor receptors. Therapeutic uses of these monoclonal antibodies by themselves and in combination with anti-neoplastic agents are also disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 17, 2001
    Assignee: Rhone-Poulenc Rorer International (Holdings), Inc.
    Inventors: Joseph Schlessinger, David Givol, Francoise Bellot, Richard Kris, George A. Ricca, Christopher Cheadle, Victoria J. South
  • Expression cloning of c-src SH3-domain binding proteins
    Patent number: 5541109
    Abstract: This invention provides a unique SH3 binding domain core motif of the sequence RPLPXXP and cDNA clones encoding proteins which interact with the SH3 domain of c-src, as well as the amino acid sequences which mediate this binding.Another embodiment of this invention is a method of identifying SH3-binding proteins and elucidating the sequences which mediate binding. This method may be used as an assay to select compounds which bind to this site and which inhibit or enhance the binding of the SH3 domain.
    Type: Grant
    Filed: April 19, 1994
    Date of Patent: July 30, 1996
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.
    Inventors: George H. Searfoss, III, Yuri D. Ivashchenko, Michael C. Jaye, Victoria J. South, Stephen M. French, Christopher Cheadle, George A. Ricca